Optimizing Vitality with Recovery Factors®

Principle Investigators: Jacob Teitelbaum, MD[1], Gaetano Morello, ND[2]

[1] Kona Research Center
[2] Complex Chronic Disease Program, BC Woman’s Hospital, Vancouver, B.C.

Abstract

Objectives: Low energy, nonrestorative sleep, cognitive dysfunction, and widespread discomfort affects a large percent of the adult population. Approaches to optimize vitality are a critical area of research focus. Clinical experience suggested that a unique porcine serum polypeptide extract resulted in dramatic improvement in many cases. The purpose of this initial pilot study was to explore the effects of this unique form of nutritional support.

Design, Location, and Subjects: An open-label, unblinded study of 43 people recruited worldwide from the investigator’s (JT) practice and newsletter. Inclusion criteria required that they rate their energy level at five or less on a 0 to 10 scale, accompanied by nonrestorative sleep and widespread discomfort.

Interventions: 43 subjects received Recovery Factors 4 tablets twice daily after an initial loading dose. 37 of these received treatment for six weeks and six who were included in the trial but also had pre- and post total IgG and IgG 1-4 subset levels tested received the supplement for 10 weeks.

Outcome Measures: All patients were assessed at baseline and after treatment using a Visual Analog Scale (1-10 points) rating energy, sleep, cognitive function, pain, overall well being, anxiety and digestive health. The principal outcome measure was the pre- and post composite score for the first five symptoms. FIQ-R was also checked, as was the person’s overall assessment of much worse, worse, no change, better, or much better.

Results: 43 subjects patients completed the 3 week treatment trial. 60.5% of subjects rated themselves as improved, with 18.6% rating themselves as much better.

In the 60.5% of subjects who improved, marked average improvement was seen in all categories:

• 69.5% average increase in energy
• 69.2% average increase in overall well being
• 54.1% average improvement in sleep
• 60.5% average improvement in mental clarity
• 37.9% average decrease in discomfort
• 34.8% average improvement in calmness
• 54.6% average improvement in digestive symptoms

FIQ-R decreased from 59.2 to 39.3.

In the six people who also had pre- and post IgG antibody levels (selected because they had either low total IgG or IgG 1-4 subsets), total IgG increased by 13.8% on average, with similar improvements seen in the subsets.

Conclusions: Recovery Factors resulted in markedly improved energy levels, sleep, mental clarity, pain relief, calming, digestive symptom improvement and overall well-being.